GLYCOPYRROLATE
NDC 75834-195, glycopyrrolate, injection, from Nivagen Pharmaceuticals, Inc..
- Product NDC
- 75834-195
- Status
- Listed
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212591
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75834-195 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCOPYRROLATE.2 mg/mL
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75834-195-25 | 75834019525 | 25 VIAL, MULTI-DOSE in 1 CARTON (75834-195-25) / 5 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177
Use it
Look up 75834-195 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75834-195 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75834-195. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.